Brokerages Set CryoPort, Inc. (NASDAQ:CYRX) PT at $12.83

CryoPort, Inc. (NASDAQ:CYRX) has earned an average rating of “Moderate Buy” from the ten research firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eight have given a buy rating to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $12.8333.

CYRX has been the topic of a number of research reports. UBS Group increased their target price on shares of CryoPort from $11.00 to $12.50 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Needham & Company LLC increased their price objective on CryoPort from $11.00 to $12.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of CryoPort in a research note on Monday, December 29th.

Insider Activity at CryoPort

In other news, Director Ramkumar Mandalam sold 11,570 shares of the business’s stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $9.99, for a total transaction of $115,584.30. Following the completion of the transaction, the director directly owned 80,758 shares of the company’s stock, valued at approximately $806,772.42. The trade was a 12.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 10.00% of the company’s stock.

Institutional Investors Weigh In On CryoPort

Large investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of CryoPort by 2.5% during the 3rd quarter. Vanguard Group Inc. now owns 2,858,031 shares of the company’s stock worth $27,094,000 after purchasing an additional 69,550 shares during the last quarter. Millennium Management LLC raised its stake in CryoPort by 18.5% in the third quarter. Millennium Management LLC now owns 2,620,906 shares of the company’s stock valued at $24,846,000 after buying an additional 408,335 shares in the last quarter. Thematics Asset Management raised its stake in CryoPort by 12.8% in the second quarter. Thematics Asset Management now owns 1,914,885 shares of the company’s stock valued at $14,285,000 after buying an additional 216,937 shares in the last quarter. Assenagon Asset Management S.A. lifted its holdings in CryoPort by 37.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,498,774 shares of the company’s stock worth $14,208,000 after buying an additional 408,263 shares during the last quarter. Finally, UBS Group AG boosted its position in shares of CryoPort by 6.8% during the 4th quarter. UBS Group AG now owns 1,421,884 shares of the company’s stock worth $13,650,000 after acquiring an additional 90,363 shares in the last quarter. 92.90% of the stock is owned by hedge funds and other institutional investors.

CryoPort Price Performance

CYRX opened at $8.72 on Friday. The stock’s 50-day moving average price is $9.88 and its 200 day moving average price is $9.33. CryoPort has a 12-month low of $4.58 and a 12-month high of $11.45. The firm has a market cap of $436.61 million, a price-to-earnings ratio of 7.45 and a beta of 1.66. The company has a current ratio of 15.77, a quick ratio of 15.01 and a debt-to-equity ratio of 0.40.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.